Section Arrow
RVTY.NYSE
- Revvity
Quotes are at least 15-min delayed:2026/02/25 04:57 EST
Pre Market
Last
 --
-- (--)
Bid
39.05
Ask
115
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 97.62
+0.5 (+0.51%)
Day High 
99.48 
Prev. Close
97.12 
1-M High
118.21 
Volume 
705.52K 
Bid
39.05
Ask
115
Day Low
97.13 
Open
97.13 
1-M Low
93.7 
Market Cap 
11.01B 
Currency 美元 
P/E 50.06 
%Yield 0.29 
10-SMA 99.04 
20-SMA 103.07 
50-SMA 103.29 
52-W High 120.39 
52-W Low 81.36 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.99/6.30
Enterprise Value
14.31B
Balance Sheet
Book Value Per Share
63.95
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
3.31B
Operating Revenue Per Share
24.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
XWELXWELL0.378+0.037+10.85%-- 
Pre Market 0.8302 +0.4522 +119.63%
MYGNMyriad Genetics4.43+0.03+0.68%-- 
Pre Market 4.36 -0.07 -1.58%
GRALGRAIL Inc.50.35+7.32+17.01%-- 
Pre Market 49.9 -0.45 -0.89%
DHRDanaher Corp209.19-1.73-0.82%43.4PE
Pre Market 208.86 -0.33 -0.16%
AAgilent Technologies124.4+0.2+0.16%27.18PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.